Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | November 21, 2024 | November 25, 2024 |
| GENERAL ELECTRIC COGE · Entity 2813 | Director | April 02, 2018 | April 02, 2018 |
| MORGAN STANLEYMS · Entity 2815 | Director | July 28, 2026 | July 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date November 21, 2024 · Filed November 25, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 24,436.9156 |
Reported balance
After 2024-11-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-11-21 · Grant · Acquired 2,933.4501 · Balance 24,436.9156 F1: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. F2: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person. |
| Common StockSEC Table I · non-derivative | Direct | 11,843.9977 |
Reported balance
Holding disclosure · report date 2024-11-21 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,843.9977 |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
F2: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.
GENERAL ELECTRIC CO
Report date April 02, 2018 · Filed April 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Fee Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 47,459 |
Reported balance
After 2018-04-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-04-02 · Grant · Acquired 5,071 · Balance 47,459 F1: Acquired at a price of $14.06 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2: Each unit of phantom stock is the economic equivalent of one share of common stock. F3: Payable beginning one year after termination of service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquired at a price of $14.06 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director.
F2: Each unit of phantom stock is the economic equivalent of one share of common stock.
F3: Payable beginning one year after termination of service as a director.
MORGAN STANLEY
Report date July 28, 2026 · Filed July 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,517.588 |
Ending reported balance
After 2026-07-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-07-28 · Sale · Disposed 1,000 · Balance 40,842.588 Row 2 · 2026-07-28 · Gift · Disposed 2,325 · Balance 38,517.588 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Jul 29, 2026 20:06 UTC | MORGAN STANLEY MS · Entity 2815 | GiftCommon Stock | 2,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-050605 · wk-form4_1785355597.xml · nonDerivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,517.588 Read SEC document |
| July 28, 2026 Filed Jul 29, 2026 20:06 UTC | MORGAN STANLEY MS · Entity 2815 | SaleCommon Stock | 1,000 | $212.06 | $212,055.00 |
DisclosureSEC source: 0001628280-26-050605 · wk-form4_1785355597.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,842.588 Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 21:05 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 1,309.777 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-039852 · wk-form4_1780434323.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,842.588 F1 · kind: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:07 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 450.686 | $127.58 | $57,500.01 |
DisclosureSEC source: 0001628280-25-029029 · wk-form4_1748981251.xml · nonDerivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,646.877 F2 · kind: Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers paid for service on the Morgan Stanley Board of Directors. Stock units are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:07 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 2,155.455 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029029 · wk-form4_1748981251.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,196.191 F1 · kind: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 21:25 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 378.687 | $132.04 | $50,000.01 |
DisclosureSEC source: 0001628280-24-049765 · wk-form4_1733261137.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,581.595 F1 · kind: Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers paid for service on the Morgan Stanley Board of Directors. Stock units are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 22:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantDeferred Stock Units · Derivative | 2,933.4501 | $57.10 Strike: $0.00 | $167,500.00 |
DisclosureSEC source: 0001127602-24-028006 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,436.9156 Underlying: Common Stock · 2,933.4501 shares Expires not disclosed F1 · shares: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person. F2 · derivative.expiration_date: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person. Read SEC document |
| June 01, 2024 Filed Jun 3, 2024 20:22 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 2,675.293 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026340 · wk-form4_1717446116.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,676.589 F1 · kind: Restricted Stock Units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,912.0306 | $57.52 Strike: $0.00 | $167,500.00 |
DisclosureSEC source: 0001127602-24-015904 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,017.4328 Underlying: Common Stock · 2,912.0306 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,817.2284 | $69.13 Strike: $0.00 | $125,625.00 |
DisclosureSEC source: 0001127602-23-027848 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,734.5362 Underlying: Common Stock · 1,817.2284 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:25 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 609.197 | $82.08 | $49,999.97 |
DisclosureSEC source: 0001209191-23-033730 · doc4.xml · nonDerivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,866.498 F2 · kind: Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers paid for service on the Morgan Stanley Board of Directors. Stock units are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:25 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 3,167.827 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033730 · doc4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,257.301 F1 · kind: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,329.1733 | $69.31 Strike: $0.00 | $92,125.00 |
DisclosureSEC source: 0001127602-23-016326 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,534.0707 Underlying: Common Stock · 1,329.1733 shares Expires not disclosed F1 · kind: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:06 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 511.782 | $92.81 | $47,500.02 |
DisclosureSEC source: 0001209191-22-059395 · doc4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,668.754 F1 · kind: Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers paid for service on the Morgan Stanley Board of Directors. Stock units are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,764.458 | $94.93 Strike: $0.00 | $167,500.00 |
DisclosureSEC source: 0001127602-22-026174 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,107.3441 Underlying: Common Stock · 1,764.458 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:14 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 2,944.606 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034012 · doc4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,754.462 F1 · kind: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,709.3581 | $97.99 Strike: $0.00 | $167,500.00 |
DisclosureSEC source: 0001127602-22-014455 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,142.2024 Underlying: Common Stock · 1,709.3581 shares Expires not disclosed F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,253.6396 | $92.73 Strike: $0.00 | $116,250.00 |
DisclosureSEC source: 0001127602-21-029709 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,638.1248 Underlying: Common Stock · 1,253.6396 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 417 | $92.73 | $38,668.41 |
DisclosureSEC source: 0001127602-21-029709 · form4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:50 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 2,702.948 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037843 · doc4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,218.023 F1 · kind: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,379.4945 | $84.27 Strike: $0.00 | $116,250.00 |
DisclosureSEC source: 0001127602-21-016886 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,230.7911 Underlying: Common Stock · 1,379.4945 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 459 | $84.27 | $38,679.93 |
DisclosureSEC source: 0001127602-21-016886 · form4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,168 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 22:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,336 | $66.35 | $154,993.60 |
DisclosureSEC source: 0001127602-20-029741 · form4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,709 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:14 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 1,061.64 | $44.74 | $47,500.00 |
DisclosureSEC source: 0001209191-20-033962 · doc4.xml · nonDerivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,144.994 F2 · kind: Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers paid for service on the Morgan Stanley Board of Directors. Stock units are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:14 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 5,587.579 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033962 · doc4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,083.354 F1 · kind: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,487 | $62.31 | $154,964.97 |
DisclosureSEC source: 0001127602-20-016774 · form4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,373 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| December 01, 2019 Filed Dec 2, 2019 21:22 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 958.258 | $49.57 | $47,499.99 |
DisclosureSEC source: 0001209191-19-058539 · doc4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,288.171 F1 · kind: Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers paid for service on the Morgan Stanley Board of Directors. Stock units are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 21:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,293.0459 | $74.92 Strike: $0.00 | $96,875.00 |
DisclosureSEC source: 0001127602-19-033567 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,324.0634 Underlying: Common Stock · 1,293.0459 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 21:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 775 | $74.92 | $58,063.00 |
DisclosureSEC source: 0001127602-19-033567 · form4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,886 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:24 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 1,160.85 | $40.92 | $47,500.01 |
DisclosureSEC source: 0001209191-19-034264 · doc4.xml · nonDerivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,133.965 F2 · kind: Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers paid for service on the Morgan Stanley Board of Directors. Stock units are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:24 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 6,109.736 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-034264 · doc4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,973.115 F1 · kind: Restricted stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,852.2945 | $52.30 Strike: $0.00 | $96,875.00 |
DisclosureSEC source: 0001127602-19-019153 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,869.2638 Underlying: Common Stock · 1,852.2945 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,111 | $52.30 | $58,105.30 |
DisclosureSEC source: 0001127602-19-019153 · form4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111 Read SEC document |
| December 01, 2018 Filed Dec 4, 2018 21:17 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 639.968 | $44.27 | $28,333.30 |
DisclosureSEC source: 0001209191-18-060845 · doc4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,795.951 F1 · kind: Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan in lieu of cash retainers paid for service on the Morgan Stanley Board of Directors. Stock units are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,777.3264 | $78.77 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-18-032664 · form4.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,887.0105 Underlying: Common Stock · 1,777.3264 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 21:02 UTC | MORGAN STANLEY MS · Entity 2815 | GrantCommon Stock | 4,127.742 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-045010 · doc4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,127.742 F1 · kind: Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,184.0874 | $64.10 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-18-020148 · form4.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,021.9237 Underlying: Common Stock · 2,184.0874 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| April 02, 2018 Filed Apr 2, 2018 20:32 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 5,071 | $14.06 | $71,298.26 |
DisclosureSEC source: 0001231205-18-000061 · edgar.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,459 Underlying: Common Stock · 5,071 shares Expires not disclosed F1 · security: Acquired at a price of $14.06 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:34 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 4,041 | $17.64 | $71,283.24 |
DisclosureSEC source: 0001231205-18-000024 · edgar.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,105 Underlying: Common Stock · 4,041 shares Expires not disclosed F1 · security: Acquired at a price of $17.64 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,029.2796 | $68.99 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-17-031743 · form4.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,782.5271 Underlying: Common Stock · 2,029.2796 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. The share credits are scheduled to be settled in common stock in 2022. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 20:06 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 2,922 | $24.40 | $71,296.80 |
DisclosureSEC source: 0001231205-17-000108 · edgar.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,676 Underlying: Common Stock · 2,922 shares Expires not disclosed F1 · security: Acquired at a price of $24.40 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 20:20 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 2,551 | $27.95 | $71,300.45 |
DisclosureSEC source: 0001231205-17-000075 · edgar.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,453 Underlying: Common Stock · 2,551 shares Expires not disclosed F1 · security: Acquired at a price of $27.95 per unit pursuant to the terms of the 2003 Non-Employee Director Compensation Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| May 10, 2017 Filed May 12, 2017 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,729.6763 | $80.94 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-17-017939 · form4.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,729.6763 Underlying: Common Stock · 1,729.6763 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| April 03, 2017 Filed Apr 3, 2017 20:15 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 2,397 | $29.74 | $71,286.78 |
DisclosureSEC source: 0001231205-17-000043 · edgar.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,663 Underlying: Common Stock · 2,397 shares Expires not disclosed F1 · security: Acquired at a price of $29.74 per unit pursuant to the terms of the 2003 Non-Employee Director Compensation Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:30 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 2,251 | $31.68 | $71,311.68 |
DisclosureSEC source: 0001231205-17-000017 · edgar.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,054 Underlying: Common Stock · 2,251 shares Expires not disclosed F1 · security: Acquired at a price of $31.68 per unit pursuant to the terms of the 2003 Non-Employee Director Compensation Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:18 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 2,371 | $30.07 | $71,295.97 |
DisclosureSEC source: 0001231205-16-000196 · edgar.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,609 Underlying: Common Stock · 2,371 shares Expires not disclosed F1 · security: Acquired at a price of $30.07 per unit pursuant to the terms of the 2003 Non-Employee Director Compensation Plan. Payable beginning one year after termination of service as a director. F4 · security: All transactions reported on this Form 4 were conducted outside a trading venue. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| July 01, 2016 Filed Jul 5, 2016 20:11 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 2,081 | $30.39 | $63,241.59 |
DisclosureSEC source: 0001231205-16-000153 · edgar.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,078 Underlying: Common Stock · 2,081 shares Expires not disclosed F1 · security: Acquired at a price of $30.39 per unit pursuant to the terms of the 2003 Non-Employee Director Compensation Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| April 01, 2016 Filed Apr 4, 2016 20:33 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 2,049 | $30.74 | $62,986.26 |
DisclosureSEC source: 0001231205-16-000126 · edgar.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,848 Underlying: Common Stock · 2,049 shares Expires not disclosed F1 · security: Acquired at a price of $30.74 per unit pursuant to the terms of the 2003 Non-Employee Director Compensation Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| January 04, 2016 Filed Jan 4, 2016 22:49 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 2,059 | $30.60 | $63,005.40 |
DisclosureSEC source: 0001231205-16-000102 · edgar.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,654 Underlying: Common Stock · 2,059 shares Expires not disclosed F1 · security: Acquired at a price of $30.60 per unit pursuant to the terms of the 2003 Non-Employee Director Compensation Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| October 01, 2015 Filed Oct 2, 2015 18:41 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 2,532 | $24.88 | $62,996.16 |
DisclosureSEC source: 0001231205-15-000074 · edgar.xml · derivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,479 Underlying: Common Stock · 2,532 shares Expires not disclosed F1 · security: Acquired at a price of $24.88 per unit pursuant to the terms of the 2003 Non-Employee Director Compensation Plan. Payable beginning one year after termination of service as a director. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.